Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

pterostilbene

A naturally-derived stilbenoid structurally related to resveratrol, with potential antioxidant, anti-inflammatory, pro-apoptotic, antineoplastic and cytoprotective activities. Upon administration, pterostilbene exerts its antioxidant activity by scavenging reactive oxygen species (ROS), thereby preventing oxidative stress and ROS-induced cell damage. It may also activate the nuclear factor erythroid 2-related factor 2 (Nrf2)-mediated pathway and increase the expression of various antioxidant enzymes, such as superoxide dismutase (SOD). In addition, pterostilbene is able to inhibit inflammation by reducing the expression of various inflammatory mediators, such as interleukin (IL) 1beta, tumor necrosis factor alpha (TNF-a), inducible nitric oxide synthase (iNOS), cyclooxygenases (COX), and nuclear factor kappa B (NF-kB). It also inhibits or prevents the activation of many signaling pathways involved in carcinogenesis, increases expression of various tumor suppressor genes while decreasing expression of certain tumor promoting genes and directly induces apoptosis in tumor cells.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Chemical structure:3',5'-dimethoxy-4-stilbenol (SY); 3,5-dimethoxy-4'-hydroxystilbene
phenol, 4-(2-(3,5-dimethoxyphenyl)ethenyl)-, (E)-
trans-3,5-dimethoxy-4-hydroxystilbene
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search